CliffBio
small molecule

DIMETHYL FUMARATE

DIMETHYL FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyTWI PHARMACEUTICALS INC

Drug detail

Brand nameDIMETHYL FUMARATE
Active ingredientDIMETHYL FUMARATE
Strength240MG
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2020
Marketing statusRX

More from TWI PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.